Physiological Study of the Critical Closing Airway Pressure in a Population of Didgeridoo Players (SASDICrit)

Obstructive sleep apnea is characterised by an abnormal upper airway collapsibility. Upper airway collapsibility can be evaluated through critical closure airway pressure (Pcrit). Didgeridoo is a traditional australian musical instrument involving circular respiration, a breathing technique involving mouth muscles. We hypothesize that didgeridoo players have a lower risk of airway collapsibility due to circular breathing technique

Study Overview

• Status: Completed
• Conditions: Sleep Apnea Syndromes
• Intervention / Treatment: Other: Measurement of critical airway closing pressure; Other: Respiratory function tests; Other: pharyngometry

Detailed Description

Some studies have shown the benefit of playing the didgeridoo, a wind musical instrument of Aboriginal origin, on the risk of obstructive sleep apnea hypopnea syndrome (OSAHS) and on OSAHS itself. Thus, didgeridoo players are less at risk of OSAHS and the practice of this instrument reduces the severity of this syndrome. To date, there are very few studies on the physiological mechanisms involved in the practice of the didgeridoo to explain this reduction in risk and impact on OSAHS.

The rare studies carried out show a great participation of the dilator muscles of the pharynx. We can also note that the didgeridoo is practiced with a particular breathing technique allowing air to be expelled while inhaling. This technique is called circular breathing. This breathing is acquired by working on the control of these dilator muscles of the pharynx but also by becoming aware of its ventilatory needs. Thus it is for the players to learn to breathe according to the needs without disturbing the piece. This respiratory learning, ventilation modulation, not explored until now, could influence the sensitivity of the central and peripheral chemoreceptors of the player with respect to his pCO2 and his pO2. We know the role of this sensitivity in the pathophysiology of SAS.

In this work we therefore seek to highlight a benefit to the practice of the didgeridoo on the critical pressure of pharyngeal closure involving the dilator muscles of the pharynx but also a benefit in terms of gas exchange by analyzing the slope of response to CO2 .

We will compare the effect of using the didgeridoo with that of another wind instrument, the oboe, on these respiratory parameters.

We chose this instrument because a study showed a lower risk of SAS in a population of oboe players. However, in the practice of this instrument, circular breathing is not used.

It would therefore be a comparative observational study with the recruitment of three groups of subjects in order to:

• Compare didgeridoo players with subjects not playing a wind instrument;
• Compare didgeridoo players with players of another wind instrument. There is no fixed reference value for Pcrit in healthy subjects, partly due to the heterogeneity of VAS collapsibility in healthy subjects (Pcrit is between -5 and -25 cm d water according to the studies), and on the other hand the wide variety of measurement methods. It is therefore necessary to have control groups.

Given the epidemiology of obstructive SAS and the exploratory nature of this study, we decided to include only male subjects, which will also make it possible to eliminate the effects of sex on respiratory chemosensitivity. Similarly, given the epidemiology of SAS, an age limit of 85 years was introduced in order not to overlook the effects of aging on the collapsibility of the VAS and chemosensitivity.

Finally, subjects will be matched on age (+/- 5 years) and body mass index (BMI, +/- 2.5 kg/m2) as there is a relationship between age/BMI and the collapsibility of the VAS on the one hand, and between age/BMI and the occurrence of SAS on the other hand.

"

• Study Type: Interventional
• Enrollment (Actual): 41
• Phase: Not Applicable

Contacts and Locations

Study Locations

• France
  • Paris, France, 75018
    • Justine Frija

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years to 85 years (Adult, Older Adult)
• Accepts Healthy Volunteers: Yes

Description

Inclusion criteria :

• Male patient
• Age ≥18 and ≤85 years old
• Free, informed and written consent
• Affiliation to a social security scheme

For "Didgeridoo players" group:

- Regular practice of the didgeridoo defined by a practice of more than 3 times a week, for more than 1 year and having acquired the circular breathing technique.

For "Oboe players" group:

- Regular practice of the oboe defined by a practice of more than 3 sessions per week for more than 1 year.

For "Control cases" group:

- Patient free from SAS and at low risk of SAS on the Berlin questionnaire and the STOP BANG questionnaire.

Exclusion criteria :

• Participation in a research protocol involving the human person in the previous months if an exclusion instruction is given in this protocol
• Use of respiratory depressants or sedatives, systemic corticosteroid therapy
• Unstable cardiovascular disease (cardiovascular event less than a month old)
• Recent ENT surgery (less than 6 months)
• Known central neurological pathology
• Psychiatric pathology according to DSM-V criteria, unbalanced
• Pulsed oxyhemoglobin saturation < 88% at rest, while awake
• Patient under guardianship or curators
• Patient under AME
• Absence of prior medical examination"

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Other
• Allocation: Non-Randomized
• Interventional Model: Parallel Assignment
• Masking: None (Open Label)

Number of Arms

3

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Other: didgeridoo players; subjects having a regular practice of didgeridoo	Other: Measurement of critical airway closing pressure; Measurement of critical airway closing pressure; Other: Respiratory function tests; CO2 response test; Other: pharyngometry; measure of the pharyngometry
Other: oboe players; subjects having a regular practice of the oboe	Other: Measurement of critical airway closing pressure; Measurement of critical airway closing pressure; Other: Respiratory function tests; CO2 response test; Other: pharyngometry; measure of the pharyngometry
Other: control; control subjects without diagnosed SAS, at low risk of SAS on the Berlin questionnaire and the STOP BANG questionnaire	Other: Measurement of critical airway closing pressure; Measurement of critical airway closing pressure; Other: Respiratory function tests; CO2 response test; Other: pharyngometry; measure of the pharyngometry

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Time Frame
values of the critical closing pressure of the VAS (Pcrit) in patients of the "Didgeridoo players" group and the "control" group	one day

Secondary Outcome Measures

Outcome Measure	Time Frame
Value of the slope of response to CO2 in each of the three groups	one day
pharyngeal volume	one day

Collaborators and Investigators

• Sponsor: Assistance Publique - Hôpitaux de Paris
• Investigators: Principal Investigator: Frija-Masson Justine, MD, Assistance Publique - Hopitaux de Paris

Study record dates

Study Major Dates

• Study Start (Actual): September 16, 2021
• Primary Completion (Actual): July 7, 2023
• Study Completion (Actual): January 16, 2024

Study Registration Dates

• First Submitted: October 31, 2022
• First Submitted That Met QC Criteria: October 31, 2022
• First Posted (Actual): November 7, 2022

Study Record Updates

• Last Update Posted (Actual): March 20, 2024
• Last Update Submitted That Met QC Criteria: March 19, 2024
• Last Verified: March 1, 2024

More Information

Terms related to this study

• Keywords: sleep apnea syndrome; didgeridoo; uper airway
• Additional Relevant MeSH Terms: Nervous System Diseases; Respiratory Tract Diseases; Apnea; Respiration Disorders; Sleep Disorders, Intrinsic; Dyssomnias; Sleep Wake Disorders; Sleep Apnea Syndromes
• Other Study ID Numbers: APHP210532

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: UNDECIDED

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No